1. Functional polymorphisms in antioxidant genes in Hurthle cell thyroid neoplasm - an association of GPX1 polymorphism and recurrent Hurthle cell thyroid carcinomaBlaž Krhin, Katja Goričar, Barbara Gazić, Vita Dolžan, Nikola Bešić, 2016, izvirni znanstveni članek Povzetek: Hurthle cells of the thyroid gland are very rich in mitochondria and oxidative enzymes. As a high level oxidative metabolism may lead to higher level of oxidative stress and can be associated with an increased risk for cancer, we investigated whether common functional polymorphisms in antioxidant genes (SOD2, CAT, GPX, GSTP1, GSTM1 and GSTT1) are associated with the development or clinical course of Hurthle cell thyroid carcinoma (HCTC). Methods. A retrospective study was performed in 139 patients treated by thyroid surgery for a Hurthle cell neoplasm. HCTC, Hurthle cell thyroid adenoma (HCTA) or Hurthle cell thyroid nodule (HCTN) were diagnosed by pathomorphology. DNA was extracted from cores of histologically confirmed normal tissue obtained from formalin-fixed paraffinembedded specimens and genotyped for investigated polymorphisms. Logistic regression was used to compare genotype distributions between patient groups. Results. HCTC, HCTA and HCTN were diagnosed in 53, 47 and 21 patients, respectively. Metastatic disease and recurrence of HCTC were diagnosed in 20 and 16 HCTC patients, respectively. Genotypes and allele frequencies of investigated polymorphisms did not deviate from Hardy-Weinberg equilibrium in patients with HCTC, HCTA and HCTN. Under the dominant genetic model we observed no differences in the genotype frequency distribution of the investigated polymorphisms when the HCTA and HCTN group was compared to the HCTC group for diagnosis of HCTC or for the presence of metastatic disease. However, GPX1 polymorphism was associated with the occurrence of recurrent disease (p = 0.040). Conclusions. GPX1 polymorphism may influence the risk for recurrent disease in HCTC.
Ključne besede: Hurthle cell thyroid carcinoma, Hurthle cell neoplasm, thyroid, oxidative stress
Objavljeno v DiRROS: 30.04.2024; Ogledov: 60; Prenosov: 6
 Celotno besedilo (522,00 KB) |
2. Effectiveness of L-thyroxine treatment on TSH suppression during pregnancy in patients with a history of thyroid carcinoma after total thyroidectomy and radioiodine ablationBlaž Krhin, Nikola Bešić, 2012, izvirni znanstveni članek Povzetek: Introduction. There are scarce data about the optimal increase of L-thyroxine dose during pregnancy in patients with a history of thyroid carcinoma. The first aim of the study was to find out if routine therapeutic measures enable adequate TSH suppression in pregnancy. The other aim was to find out the optimal dose of L-thyroxine for TSH suppression in pregnant women. Patients and methods. In this retrospective observational study, we analysed 36 pregnancies of 32 women with a history of thyroid carcinoma. Before pregnancy, all of them underwent total thyroidectomy and radioiodine ablation of thyroid remnant, and they were on suppressive doses of L-thyroxine. Thyroid function tests were obtained before, during and after pregnancy. Results. Mean L-thyroxine dose before pregnancy, in the first, second and, third trimester and after delivery was 149, 147, 155, 165 and 158 micrograms daily, respectively. TSH concentration remained suppressed in 9 pregnancies, it was within normal range in 22 and elevated in 5 pregnancies. The mean dose of L-thyroxine in patients with suppressed TSH before pregnancy, in the first, second and, third trimester and after delivery was 154, 154, 164, 160 and 161 micrograms daily, respectively. When the dose had to be changed, the mean increase of the dose was 31.5 micrograms daily. Conclusions. The range of changes in TSH concentration during pregnancy in the patients who have been on suppressive L-thyroxine therapy before conception is quite wide. TSH was adequately suppressed in only 25% of pregnancies. The dose of L-thyroxine in patients with suppressed TSH in the first, second and third trimester was 154, 164 and 160 micrograms daily, respectively.
Objavljeno v DiRROS: 21.03.2024; Ogledov: 91; Prenosov: 27
Celotno besedilo (430,37 KB) |
3. Posodobljena priporočila diagnostike in zdravljenja diferenciranega raka ščitniceNikola Bešić, Alenka Grošel, Andraž Perhavec, Andrej Doma, Andreja A. Schwarzbartl-Pevec, Andreja Klevišar Ivančič, Andrej Vogrin, Barbara Vidergar-Kralj, Barbara Gazić, Barbara Perić, Blaž Krhin, Cvetka Grašič-Kuhar, Edvard Pirnat, Ivana Žagar, Jerca Blazina, Katarina Zevnik, Katica Bajuk-Studen, Katja Zaletel, Margareta Strojan Fležar, Marko Hočevar, Marko Kokalj, Marta Dremelj, Nebojša Glumac, Olga Blatnik, Simona Gaberšček, Snežana Pavlović Djokić, Ulrika Klopčič, Veronika Kloboves-Prevodnik, Zorica Čekić, 2022, strokovni članek Ključne besede: rak ščitnice, diferencirani rak, zdravljenje, smernice
Objavljeno v DiRROS: 01.07.2022; Ogledov: 818; Prenosov: 244
Celotno besedilo (432,57 KB) |
4. Posodobljena priporočila diagnostike in zdravljenja diferenciranega raka ščitniceAlenka Grošel, Andraž Perhavec, Andrej Doma, Andreja A. Schwarzbartl-Pevec, Andreja Klevišar Ivančič, Andrej Vogrin, Barbara Vidergar-Kralj, Barbara Gazić, Barbara Perić, Blaž Krhin, Cvetka Grašič-Kuhar, Edvard Pirnat, Ivana Žagar, Jerca Blazina, Katica Bajuk-Studen, Katja Zaletel, Margareta Strojan Fležar, Marko Hočevar, Marko Kokalj, Marta Dremelj, Nebojša Glumac, Nikola Bešić, Olga Blatnik, Simona Gaberšček, Snežana Pavlović Djokić, Ulrika Klopčič, Veronika Kloboves-Prevodnik, Zorica Čekić, 2020, slovar, enciklopedija, leksikon, priročnik, atlas, zemljevid Ključne besede: rak ščitnice, diferencirani rak, zdravljenje, smernice
Objavljeno v DiRROS: 12.03.2021; Ogledov: 1323; Prenosov: 413
Celotno besedilo (2,53 MB) |
5. Smernice diagnostike in zdravljenja diferenciranega raka ščitniceNikola Bešić, Andreja A. Schwarzbartl-Pevec, Andreja Klevišar Ivančič, Barbara Vidergar-Kralj, Barbara Gazić, Blaž Krhin, Branko Zakotnik, Cvetka Grašič-Kuhar, Damijan Bergant, Edvard Pirnat, Helena Gutnik, Ivana Žagar, Jerca Blazina, Katja Zaletel, Margareta Strojan Fležar, Marko Hočevar, Marta Dremelj, Nebojša Glumac, Olga Blatnik, Simona Gaberšček, Snežana Pavlović Djokić, Ulrika Klopčič, Veronika Kloboves-Prevodnik, Živa Pohar-Marinšek, 2017, slovar, enciklopedija, leksikon, priročnik, atlas, zemljevid Ključne besede: rak ščitnice, diferencirani rak, zdravljenje, smernice
Objavljeno v DiRROS: 27.05.2020; Ogledov: 1937; Prenosov: 625
Celotno besedilo (712,25 KB) |
6. Laboratorijski vodnik za pacienteAlenka Grošel, Blaž Krhin, Katarina Lenart, Barbara Možina, 2016, slovar, enciklopedija, leksikon, priročnik, atlas, zemljevid Povzetek: V pričujoči knjižici smo na enem mestu zbrali vse pomembne informacije v zvezi z odvzemom različnih bioloških vzorcev na Oddelku za laboratorijske dejavnosti Onkološkega inštituta Ljubljana.
Upamo, da boste našli uporabne informacije tudi v drugem delu knjižice, kjer so na kratko predstavljene vse laboratorijske preiskave, ki jih na oddelku izvajamo ter njihov pomen za onkološke paciente.
Ključne besede: laboratorijske preiskave, laboratorijska medicina, Onkološki inštitut Ljubljana
Objavljeno v DiRROS: 08.09.2016; Ogledov: 6324; Prenosov: 922
Celotno besedilo (1,47 MB) |
